Research, Collaboration and License Agreements - Additional Information (Details)	1 Months Ended				12 Months Ended
	Mar. 31, 2022 USD ($)	Oct. 31, 2020 USD ($)	Aug. 31, 2020 USD ($)	Apr. 30, 2020 Product	Dec. 31, 2025 USD ($) shares	Dec. 31, 2024 USD ($) shares	Dec. 31, 2023 USD ($)	Dec. 31, 2021 USD ($)	Dec. 31, 2020 USD ($)	Oct. 29, 2020 USD ($)	Nov. 30, 2019 shares
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Common stock, shares issued | shares					285,051,648	204,943,306
Research and development					$ 86,403,000	$ 66,001,000
UT Southwestern Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Preclinical activities period under sponsored research agreements				2 years
Minimum licensed product to develop obtain regulatory approval for and commercialize | Product				1
Common stock, shares issued | shares											2,179,000
Percentage of fully diluted common stock shares outstanding											20.00%
Abeona CLN1 Agreements
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Additional milestone payments					0	$ 0
License fee payment			$ 3,000,000
Purchase of clinical materials and reimbursement incurred development costs		$ 4,000,000
Research and development								$ 3,000,000	$ 7,000,000
Abeona CLN1 Agreements | Maximum
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
License and inventory purchase agreement regulatory related milestones payment			26,000,000
License and inventory purchase agreement sales related milestones payment			$ 30,000,000
Abeona | Abeona Rett Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Additional milestone payments					0
Research and development	$ 1,000,000				$ 3,000,000		$ 3,500,000
Payment of one-time upfront license fee									$ 3,000,000
Abeona | Maximum | Abeona Rett Agreement
Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items]
Regulatory related milestones obligation payable										$ 26,500,000
Sale-related milestones per licensed product and royalties on net sales of licensed products payable										$ 30,000,000